(1) Whether, in accordance with the National Drug Master Plan, all departments have submitted their (a) mini drug master plan for the 2010-11 financial year to the Central Drug Authority and (b) departmental reports on the operation of such plans for the 2009-10 financial year; if not, (i) which departments failed to submit these plans and reports by the due deadline and (ii) what were the reasons for the delay in each case; (2) whether any departments have still not submitted their (a) drug master plans and (b) reports on how operational plans were implemented; if so, (i) which departments in each case and (ii) what action does she intend taking to compel departments to comply?